N-Acetyl Cysteine (Nac) for Immune Function

Research suggests that NAC may support immune function primarily through its antioxidant and anti-inflammatory properties, with the most directly relevant evidence coming from an animal study showing that NAC helped restore immune cell populations and cytokine balance in rats experiencing pesticide-induced immune suppression, and from a CRISPR-based cell and mouse study finding that NAC suppressed SARS-CoV-2 infection across multiple variants by reducing reactive oxygen species early in viral replication. A narrative review of proposed COVID-19 interventions also listed NAC as a candidate anti-inflammatory agent, though the authors explicitly noted the absence of validated clinical evidence at the time. Notably, one mouse transplant study found that NAC acted as a pro-oxidant on immune cells in the context of bone marrow transplantation and failed to prevent graft-versus-host disease, a reminder that NAC's effects on immune function are context-dependent and not uniformly beneficial. The majority of studies in this collection are animal or cell-based models rather than randomized controlled trials in humans, which substantially limits the conclusions that can be drawn about NAC's effects on immune function in healthy or clinical human populations.